Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. [electronic resource]
Producer: 20091014Description: 633-43 p. digitalISSN:- 1938-3673
- Adenocarcinoma -- metabolism
- Animals
- Annexin A5 -- metabolism
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Colitis -- chemically induced
- Colonic Neoplasms -- metabolism
- Cytokines -- antagonists & inhibitors
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fluorescein-5-isothiocyanate -- metabolism
- HMGB1 Protein -- metabolism
- In Situ Nick-End Labeling
- Interleukin-10 -- deficiency
- Interleukin-12 Subunit p40 -- metabolism
- Intestinal Mucosa -- metabolism
- Liver Neoplasms -- metabolism
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Microtubule-Associated Proteins -- metabolism
- Neoplasm Metastasis
- Neoplasm Transplantation
- Nitric Oxide -- metabolism
- Poly (ADP-Ribose) Polymerase-1
- Poly(ADP-ribose) Polymerases -- metabolism
- Pyruvates -- metabolism
- Random Allocation
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic -- metabolism
- Transfection
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.